SRPTSarepta Therapeutics,, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 22059
Ticker: SRPT
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 1997-06-04
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: SRPT

Detail

Enriched 2026-08-14 20:47

Market cap: $1,941,424,645.98
Shares outstanding (class): 105,627,021
Shares outstanding (weighted): 105,627,021
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 835
Location: CAMBRIDGE, MA
Homepage: https://www.sarepta.com
Description: Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

Market cap and share counts drift.

Funds holding this security

159 funds · 162 positions · $723.01M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
iShares Core S&P Small-Cap ETF iShares Trust	IJR	$136.85M	0.15%	6,289,013 NS	FIGI
First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund	FBT	$73.64M	3.24%	3,384,344 NS	FIGI
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$69.90M	0.00%	3,212,305 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$66.52M	0.89%	3,057,030 NS	FIGI
VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS	VB	$50.34M	0.03%	2,313,316 NS	FIGI
VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS	VBK	$28.12M	0.07%	1,292,253 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$25.44M	0.03%	1,169,266 NS	FIGI
abrdn Healthcare Opportunities Fund —	—	$20.91M	2.90%	961,017 NS	FIGI
State Street(R) SPDR(R) Portfolio S&P 600(TM) S… SPDR SERIES TRUST	SPSM	$20.58M	0.15%	945,593 NS	FIGI
abrdn Healthcare Investors —	—	$20.49M	1.80%	941,560 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$16.09M	0.20%	739,607 NS	FIGI
VANGUARD TAX-MANAGED SMALL-CAP FUND VANGUARD TAX-MANAGED FUNDS	—	$15.22M	0.16%	699,514 NS	FIGI
VANGUARD STRATEGIC EQUITY FUND VANGUARD HORIZON FUNDS	—	$12.65M	0.13%	581,362 NS	FIGI
T. Rowe Price Small-Cap Value Fund, Inc. T. ROWE PRICE SMALL-CAP VALUE FUND, INC.	—	$12.22M	0.13%	561,374 NS	FIGI
iShares Russell Mid-Cap Growth ETF iShares Trust	IWP	$12.00M	0.06%	551,681 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERSRPT
FIGI_COMPOSITEBBG000BCJ161
FIGI_SHARE_CLASSBBG001S6KJC6
CIK0000873303
ISINUS8036071004
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.9
Model: deepseek
Rationale: SIC 2834 indicates pharmaceutical preparations, and Sarepta is a biopharmaceutical company.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.